If AFP is elevated, where is cancer? The case report on hereditary persistence of Alpha-fetoprotein

Hatice SARACOGLU Department of Medical Biochemistry, Faculty of Medicine, Erciyes University, Kayseri/Turkey Mevlut BASKOL Hakan SARACOGLU Department of Medical Biochemistry, Faculty of Medicine, Erciyes University, Kayseri/Turkey

Keywords: Hereditary persistence of alpha-fetoprotein, HPAFP, AFP, Hepatocellular carcinoma

Abstract

Alpha-fetoprotein (AFP) is expressed by tumors with a high mitotic index such as hepatocellular carcinoma and germ cell tumors, therefore it is used as a tumor biomarker. Interestingly, although there is no underlying cause, elevated AFP has been reported in some genetically predisposed individuals. This is a very rare and benign condition called “hereditary persistence of AFP (HPAFP)” and an inherited in an autosomal dominant manner. To our knowledge, only 28 families have been reported to date. Some of the reported cases received inappropriate treatments such as chemotherapy and surgery. The possibility of HPAFP should be kept in mind in patients with high AFP in the absence of radiological evidence of hepatocellular carcinoma or germ cell tumor to avoid harmful
procedures. It can be easily confirmed by analyzing AFP levels in other family members. We report a case of HPAFP with surprisingly higher AFP levels than previously reported cases and this is the first case reported from Turkey.

Copyright for articles published in this journal is retained by the journal.

留言 (0)

沒有登入
gif